BAC Stock Overview
Through its subsidiary, Nature’s Farm Pte Ltd, trades in health food products and supplements in Singapore and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Camsing Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.11 |
| 52 Week High | S$0.18 |
| 52 Week Low | S$0.093 |
| Beta | 0.33 |
| 11 Month Change | 0% |
| 3 Month Change | -30.00% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -88.80% |
Recent News & Updates
Recent updates
Shareholder Returns
| BAC | SG Retail Distributors | SG Market | |
|---|---|---|---|
| 7D | 0% | -1.8% | 0.5% |
| 1Y | n/a | 5.4% | 14.1% |
Return vs Industry: Insufficient data to determine how BAC performed against the SG Retail Distributors industry.
Return vs Market: Insufficient data to determine how BAC performed against the SG Market.
Price Volatility
| BAC volatility | |
|---|---|
| BAC Average Weekly Movement | n/a |
| Retail Distributors Industry Average Movement | 4.1% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in SG Market | 14.4% |
| 10% least volatile stocks in SG Market | 2.1% |
Stable Share Price: BAC's share price has been volatile over the past 3 months compared to the SG market.
Volatility Over Time: Insufficient data to determine BAC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | n/a | Choon Tat Yeo | n/a |
Camsing Healthcare Limited, through its subsidiary, Nature’s Farm Pte Ltd, trades in health food products and supplements in Singapore and internationally. It sells its products through retail. Camsing Healthcare Limited was formerly known as Jacks International Limited and changed its name to Camsing Healthcare Limited in March 2016.
Camsing Healthcare Limited Fundamentals Summary
| BAC fundamental statistics | |
|---|---|
| Market cap | S$10.08m |
| Earnings (TTM) | -S$2.13m |
| Revenue (TTM) | S$4.66m |
2.2x
P/S Ratio-4.7x
P/E RatioIs BAC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BAC income statement (TTM) | |
|---|---|
| Revenue | S$4.66m |
| Cost of Revenue | S$1.86m |
| Gross Profit | S$2.80m |
| Other Expenses | S$4.93m |
| Earnings | -S$2.13m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.024 |
| Gross Margin | 60.13% |
| Net Profit Margin | -45.66% |
| Debt/Equity Ratio | -63.0% |
How did BAC perform over the long term?
See historical performance and comparison